journal
Journals Journal of Clinical and Experi...

Journal of Clinical and Experimental Hepatology

https://read.qxmd.com/read/36846504/outcome-of-patients-waitlisted-for-deceased-donor-liver-transplantation-during-covid-19-pandemic-a-single-centre-experience
#1
JOURNAL ARTICLE
Dinesh Jothimani, Evangeline Simon, Swetha Palanichamy, Sivakumar Murugesan, Hemalatha Ramachandran, Vaasudevan Sridhar, Akila Rajakumar, Ilankumaran Kaliamoorthy, Gomathy Narasimhan, Mohamed Rela
BACKGROUND AND AIM: COVID-19 pandemic has strained several healthcare resources across the world. While Liver transplantation (LT) is the only curative therapy for patients with end stage liver disease, we aimed to determine the clinical outcome of patients waitlisted for DDLT during COVID-19 pandemic. METHODS: A retrospective comparative observational study of adult patients waitlisted for DDLT from January 2019 to January 2022 at our liver unit (Dr Rela Institute and Medical Center, Chennai, Tamil Nadu, India) was carried out...
February 14, 2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36777086/chronic-liver-disease-and-cirrhosis-are-associated-with-worse-outcomes-following-sars-cov-2-infection
#2
JOURNAL ARTICLE
Robert J Wong, Yi Zhang, Mae Thamer
BACKGROUND AND AIMS: Studies evaluating the impact of SARS-CoV-2 on chronic liver disease (CLD) are limited and have focused mostly on hospitalized patients or those with cirrhosis. We aim to evaluate the impact of underlying CLD on patient outcomes following COVID-19 using a one of the largest COVID-19+CLD cohorts to date. METHODS: Data from the COVID-19 Research Database (https://covid19researchdatabase.org) were evaluated from 4/1/2020-8/31/2021 to determine whether concurrent CLD was associated with worse outcomes within 30-days of COVID-19 diagnosis, including need for hospitalization, pneumonia, severe pneumonia, respiratory failure, and multi-organ failure...
February 3, 2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647420/cytomegalovirus-hepatitis-in-an-immunocompetent-adult
#3
JOURNAL ARTICLE
Narendra S Choudhary, Vikas Deswal, Ritu Nehra, Dheeraj Gautam
No abstract text is available yet for this article.
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647419/emerging-biomarkers-in-alcohol-associated-hepatitis
#4
REVIEW
Gene Y Im
Alcohol-associated hepatitis (AH) is a clinical syndrome of jaundice, abdominal pain, and anorexia due to prolonged heavy alcohol intake. AH is associated with changes in gene expression, cytokines, immune response, and the gut microbiome. There are limited biomarkers to diagnose and prognosticate in AH, but several non-invasive biomarkers are emerging. In this review, clinical risk-stratifying algorithms, promising AH biomarkers like cytokeratin-18 fragments, genetic polymorphisms, and microRNAs will be reviewed...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647418/survival-after-resection-for-epidermoid-cyst-originated-squamous-cell-carcinoma-of-the-liver-case-report-and-review-of-the-literature
#5
Khai V Ninh, Dang H Do, Tuan Hoang, Phuong H Tran, Lanh S Nguyen, Nghia Q Nguyen
Epidermoid cyst is a rare type of congenital hepatic cyst. Reports on squamous cell carcinoma (SCC) of the liver are very limited and mostly have poor outcomes. We present a 45-year-old woman who came to our hospital due to obstructive jaundice caused by an epidermoid cyst-originated SCC. She underwent radical resection and lived for two years without signs of recurrence. The presentation, treatment, pathological results, as well as literature review, are provided below.
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647417/knowledge-awareness-and-prevalence-of-hepatitis-b-among-urban-slum-dwellers-and-residents-of-social-welfare-home-a-cross-sectional-study-from-eastern-india
#6
JOURNAL ARTICLE
Vybhav Venkatesh, Girish K Pati, Kanishka Uthansingh, Pradeep Mallick, Jimmy Narayan, Debakanta Mishra, Manoj K Sahu
BACKGROUND/AIMS: In view of limited data on the knowledge and awareness of hepatitis B virus (HBV) and the available preventive strategies at the community level, it was aimed to analyse the knowledge and awareness of HBV in the community. METHODS: A cross-sectional questionnaire-based survey was conducted among residents of an urban slum and a social welfare home in Bhubaneswar, Odisha, from October 2019 to April 2021. The prevalence of HBV infection was also measured by testing the serum positivity for hepatitis B surface antigen using rapid point-of-care test kits...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647416/spectrum-screening-and-diagnosis-of-alcohol-related-liver-disease
#7
REVIEW
Maria Hernandez-Tejero, Ana Clemente-Sanchez, Ramon Bataller
Alcohol-related liver disease (ALD) represents one of the leading causes of chronic liver disease and is a major cause of liver-related deaths worldwide. ALD encompasses a range of disorders including simple steatosis, alcoholic steatohepatitis, fibrosis, cirrhosis, and hepatocellular carcinoma. Patients with underlying ALD and continued heavy alcohol consumption can also develop an episode of acute-on-chronic liver injury called alcohol-associated hepatitis, the most severe form of the disease, which portends a poor prognosis...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647415/current-status-of-biomarkers-and-molecular-diagnostic-tools-for-rejection-in-liver-transplantation-light-at-the-end-of-the-tunnel
#8
REVIEW
Ahmed El Sabagh, Islam B Mohamed, Fuad Z Aloor, Ahmed Abdelwahab, Manal M Hassan, Prasun K Jalal
Strategies to minimize immune-suppressive medications after liver transplantation are limited by allograft rejection. Biopsy of liver is the current standard of care in diagnosing rejection. However, it adds to physical and economic burden to the patient and has diagnostic limitations. In this review, we aim to highlight the different biomarkers to predict and diagnose acute rejection. We also aim to explore recent advances in molecular diagnostics to improve the diagnostic yield of liver biopsies...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647414/sarcopenia-in-the-cirrhotic-patient-current-knowledge-and-future-directions
#9
REVIEW
Edgewood R Warner Ii, Sanjaya K Satapathy
Cirrhosis predisposes to abnormalities in energy, hormonal, and immunological homeostasis. Disturbances in these metabolic processes create susceptibility to sarcopenia or pathological muscle wasting. Sarcopenia is prevalent in cirrhosis and its presence portends significant adverse outcomes including the length of hospital stay, infectious complications, and mortality. This highlights the importance of identification of at-risk individuals with early nutritional, therapeutic and physical therapy intervention...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647413/operational-tolerance-after-liver-transplantation-first-report-from-india
#10
Vikrant Sood, Bikrant B Lal, N S Ashwini, Rajeev Khanna, Viniyendra Pamecha, Nirupama Trehanpati, Seema Alam
Operational tolerance after liver transplantation is an ideal goal to avoid long-term morbidities associated with chronic immunosuppressive medication use. It is achievable in a highly selected group of post-transplant recipients but requires long-term follow-up and strict monitoring. We hereby report a post-transplant case who achieved spontaneous operational tolerance after inadvertent immunosuppression withdrawal.
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647412/liver-transplantation-in-alcohol-related-liver-disease-and-alcohol-related-hepatitis
#11
REVIEW
Line Carolle Ntandja Wandji, Massih Ningarhari, Guillaume Lassailly, Sébastien Dharancy, Emmanuel Boleslawski, Philippe Mathurin, Alexandre Louvet
Alcohol-related liver disease (ARLD) remains one of the leading causes of chronic liver disease and the prevalence of alcohol-related cirrhosis is still increasing worldwide. Thus, ARLD is one of the leading indications for liver transplantation (LT) worldwide especially after the arrival of direct-acting antivirals for chronic hepatitis C infection. Despite the risk of alcohol relapse, the outcomes of LT for ARLD are as good as for other indications such as hepatocellular carcinoma (HCC), with 1-, 5-, and 10- year survival rates of 85%, 74%, and 59%, respectively...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647411/incidence-and-predictors-of-liver-related-events-in-patients-with-nonalcoholic-fatty-liver-disease
#12
JOURNAL ARTICLE
Shalimar, Sabreena S Sheikh, Sagnik Biswas, Manas Vaishnav, Piyush Pathak, Aditya V Pachisia, Himanshu Narang, Shubham Prasad, Shubham Mehta, Anugrah Dhooria, Shekhar Swaroop, Rithvik Golla, Ankit Agarwal, Ramesh Kumar, Subrat K Acharya
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is the commonest type of liver disease worldwide. We aimed to assess the incidence and predictors of liver-related events (LREs) and mortality in NAFLD patients. METHODS: NAFLD patients (n = 957) evaluated between January 2000 and November 2021 were included. Patients were categorised as noncirrhosis (NC), compensated cirrhosis (CC) and decompensated cirrhosis (DC), and the incidence of LRE and mortality were estimated and compared...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647410/adherence-to-medication-in-children-with-liver-disease-in-india-the-first-report-every-journey-starts-with-a-first-step
#13
EDITORIAL
Barath Jagadisan, Anil Dhawan
No abstract text is available yet for this article.
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647409/study-of-adherence-to-medication-in-pediatric-liver-diseases-sampld-study-in-indian-children
#14
JOURNAL ARTICLE
Arya Suchismita, A Ashritha, Vikrant Sood, Bikrant B Lal, Rajeev Khanna, Guresh Kumar, Seema Alam
BACKGROUND/OBJECTIVES: Adherence to medication(s) is an essential component of holistic management in any chronic disease including in post liver transplant (LT) patients. Thus, this study aimed to assess adherence to medications in Indian pediatric liver disease patients (including post LT recipients) and to identify variables affecting its occurrence. METHODS: A cross-sectional study was conducted among pediatric (<18 years of age) subjects with Wilson disease (WD) and autoimmune liver disease (AILD) along with post LT recipients from May 2021 to October 2021...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647408/new-president-of-indian-national-association-for-the-study-of-liver-professor-shivaram-prasad-singh
#15
EDITORIAL
Subrat K Acharya
No abstract text is available yet for this article.
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647407/artificial-intelligence-in-hepatology-ready-for-the-primetime
#16
REVIEW
Rakesh Kalapala, Hardik Rughwani, D Nageshwar Reddy
Artificial Intelligence (AI) is a mathematical process of computer mediating designing of algorithms to support human intelligence. AI in hepatology has shown tremendous promise to plan appropriate management and hence improve treatment outcomes. The field of AI is in a very early phase with limited clinical use. AI tools such as machine learning, deep learning, and 'big data ' are in a continuous phase of evolution, presently being applied for clinical and basic research. In this review, we have summarized various AI applications in hepatology, the pitfalls and AI's future implications...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647406/fish-oil-omega-3-exerts-protective-effect-in-oxidative-stress-and-liver-dysfunctions-resulting-from-experimental-sepsis
#17
JOURNAL ARTICLE
Mary J Soares Gonçalves Velasque, Gisele Branchini, Anderson V Catarina, Lais Bettoni, Renata S Fernandes, Arthur Ferreira Da Silva, Gilson P Dorneles, Igor Martins da Silva, Maeli A Santos, Juliana Sumienski, Alessandra Peres, Adriana V Roehe, Maria B da Fonte Kohek, Marilene Porawski, Fernanda B Nunes
BACKGROUND: Sepsis is a severe global health problem, with high morbidity and mortality. In sepsis, one of the main affected organs is the liver. Hepatic alterations characterize a negative prognostic. Omega-3 fatty acids (ω3), eicosapentaenoic acid, and docosahexaenoic acid, are part of the main families of polyunsaturated fatty acids. ω3 has been used in studies as sepsis treatment and as a treatment for non-alcoholic liver disease. AIM: We aimed to evaluate the effects of treatment with fish oil (FO) rich in ω3 on liver changes and damage resulting from experimental sepsis...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647405/frailty-and-other-indicators-for-predicting-mortality-and-hospitalization-in-patients-with-cirrhosis
#18
JOURNAL ARTICLE
Tomoyuki Kawada
No abstract text is available yet for this article.
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647404/post-paracentesis-ascitic-fluid-leak-in-patients-with-cirrhosis-of-liver-and-its-management-a-prospective-study
#19
JOURNAL ARTICLE
Suprabhat Giri, Sidharth Harindranath, Nitish Patwardhan, Aditya Kale, Akash Shukla
BACKGROUND: Ascites is the most common complication of decompensated cirrhosis of liver requiring paracentesis for diagnostic and therapeutic purposes. The ascitic fluid leak can develop after paracentesis in patients with cirrhosis leading to significant morbidity if persistent. We aimed to study the incidence and predictors of post-paracentesis leak in patients with ascites. METHODS: In this prospective study, patients with cirrhosis undergoing therapeutic paracentesis were followed up, and those patients who developed persistent leak were included as cases...
2023: Journal of Clinical and Experimental Hepatology
https://read.qxmd.com/read/36647403/emerging-pharmacotherapies-in-alcohol-associated-hepatitis
#20
REVIEW
Ali Wakil, Mumtaz Niazi, Mohamad A Meybodi, Nikolaos T Pyrsopoulos
UNLABELLED: The incidence of alcoholic-associated hepatitis (AH) is increasing. The treatment options for severe AH (sAH) are scarce and limited to corticosteroid therapy which showed limited mortality benefit in short-term use only. Therefore, there is a dire need for developing safe and effective therapies for patients with sAH and to improve their high mortality rates.This review article focuses on the current novel therapeutics targeting various mechanisms in the pathogenesis of alcohol-related hepatitis...
2023: Journal of Clinical and Experimental Hepatology
journal
journal
43854
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.